Objectives: Microorganisms contribute to the pathogenesis of obesity, while more studies focus on gut microbiome. However, the relationship between oral microbiota and obesity has yet to be elucidated. This study was designed to investigate the similarities and differences in the effects of a high-fat diet on salivary and gut microbiota through mouse experiments, exploring the hypothesis that oral microbial mechanisms may contribute to obesity.

Methods: An obese mouse model was established in male C57BL/6J mice by feeding a high-fat diet, confirmed by body weight records and blood glucose tests. This study evaluated the physiological effects of the high-fat diet on mice. 16S rRNA sequencing technology was used to analyze changes in salivary and gut microbiota, and gas chromatography-mass spectrometry was employed to evaluate 17 short-chain and medium-chain fatty acids quantitatively.

Results: The microbiota distribution in salivary was different between the high-fat diet (HFD) and normal chow diet (NCD) groups. At the genus level of salivary microbiota, and were highly abundant in the HFD group. and were more abundant in the NCD group. Regarding the gut microbiome, the diversity changes of gut microbiota are more significant than those of salivary microbiota. The HFD group had a significantly higher abundance of , , and a lower abundance of . Nine genera had consistent alterations in salivary and gut microbiota, among which , , and were significantly correlated with physiological indicators, and was significantly correlated with increased decanoic acid levels in the HFD group. The dysregulated nine genera were associated with significant upregulation of certain metabolic pathways of the HFD group, including the pentose phosphate, bacterial invasion of epithelial cells, and steroid biosynthesis pathways.

Conclusions: There are differences and similarities in the effects of HFD on salivary and gut microbiota. Certain genera of the oral-gut axis altered consistently by HFD may affect obesity through mechanisms involving metabolic pathways and inflammation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891374PMC
http://dx.doi.org/10.3389/fcimb.2025.1547555DOI Listing

Publication Analysis

Top Keywords

gut microbiota
24
high-fat diet
20
salivary gut
20
hfd group
16
effects high-fat
12
microbiota
10
salivary
8
diet salivary
8
gut
8
gut microbiome
8

Similar Publications

A Comprehensive Review of Traditional Chinese Medicine in the Management of Ulcerative Colitis.

Am J Chin Med

March 2025

School of Public Health, Nantong University, 9 Seyuan Road, Nantong, Jiangsu 226019, P. R. China.

Ulcerative colitis (UC) is a chronic, nonspecific inflammatory disorder characterized by symptoms such as abdominal pain, diarrhea, hematochezia, and urgency during defecation. While the primary site of involvement is the colon, UC can extend to encompass the entire rectum and colon. The causes and development mechanisms of UC are still not well understood; nonetheless, it is currently held that factors including environmental influences, genetic predispositions, intestinal mucosal integrity, gut microbiota composition, and immune dysregulation contribute to its development.

View Article and Find Full Text PDF

In recent years, tumor immunotherapy has made significant breakthroughs in the treatment of malignant tumors. However, individual differences in efficacy have been observed in clinical practice. There is increasing evidence that gut microbial metabolites influence the efficacy of distal tumor immunotherapy via the gut-liver axis, the gut-brain axis and the gut-breast axis, a process that may involve modulating the expression of immune cells and cytokines in the tumor microenvironment (TME).

View Article and Find Full Text PDF

Background: Liver fibrosis is characterized by hepatic stellate cell (HSC) activation and collagen overproduction, but its pathogenesis remains largely unknown. This study aimed to uncover the role of neural precursor cell expressed developmentally downregulated 4-like (Nedd4L) signaling in liver fibrosis and its relationship with gut microbiota.

Methods: Intraperitoneal injection of carbon tetrachloride (CCl) was used to induce liver fibrosis in 8-week-old female C57BL/6J mice with knockout or administration of the Nedd4L protein phosphorylation inhibitor EMD638683.

View Article and Find Full Text PDF

The COVID-19 pandemic underscored bacterial resistance as a critical global health issue, exacerbated by the increased use of antibiotics during the crisis. Notwithstanding the pandemic's prevalence, initiatives to address bacterial medication resistance have been inadequate. Although an overall drop in worldwide antibiotic consumption, total usage remains substantial, requiring rigorous regulatory measures and preventive activities to mitigate the emergence of resistance.

View Article and Find Full Text PDF

The global prevalence of allergic rhinitis (AR) remains high, posing challenges due to its chronic nature and propensity for recurrence. Gut microbiota dysbiosis contributes to immune dysregulation, impacting AR pathogenesis. () has great potential in regulating immune function to alleviate AR symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!